Clinical Trials Directory

Trials / Completed

CompletedNCT03260478

HEMOglobin Transfusion Threshold in Traumatic Brain Injury OptimizatioN: The HEMOTION Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
742 (actual)
Sponsor
CHU de Quebec-Universite Laval · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Most trauma deaths are related to traumatic brain injury (TBI). Although the management of patients has improved, mortality remains unacceptably high, and half of survivors of moderate and severe TBI are left with major functional impairment. Current management guidelines are based on limited evidence and practice is highly variable. Most acutely ill patients with TBI will develop anemia, which may decrease oxygen delivery to a fragile brain. While clinical practice is moving towards transfusing at low hemoglobin (Hb) levels, experts have expressed concerns regarding restrictive strategies, which may adversely affect clinical outcomes in TBI. Our primary objective is to evaluate the effect of red blood cell (RBC) transfusion thresholds on neurological functional outcome. We hypothesize that a liberal transfusion strategy improves outcomes compared to a restrictive strategy.

Conditions

Interventions

TypeNameDescription
PROCEDURERed Blood Cells TransfusionTransfusion of packed red blood cells unit(s).

Timeline

Start date
2017-08-31
Primary completion
2023-10-26
Completion
2024-02-16
First posted
2017-08-24
Last updated
2024-05-03

Locations

33 sites across 4 countries: Brazil, Canada, France, United Kingdom

Source: ClinicalTrials.gov record NCT03260478. Inclusion in this directory is not an endorsement.

HEMOglobin Transfusion Threshold in Traumatic Brain Injury OptimizatioN: The HEMOTION Trial (NCT03260478) · Clinical Trials Directory